Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) in Adult Patients with High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Acute Lymphoblastic Leukemia (ALL) According to Their Minimal Residual Disease (MRD). Final Results of the Pethe
暂无分享,去创建一个
J. Esteve | S. Mercadal | M. Tormo | A. Órfão | J. Ribera | S. Barrena | E. Feliú | J. Serrano | J. Bergua | P. Montesinos | J. Ribera | M. Morgades | I. Granada | J. Ciudad | M. Amigo | M. Moreno | E. Genescà | P. Martínez-Sánchez | C. Gil | P. Barba | R. Coll | S. Vives | Daniel Martínez-Carballeira | J. González-Campos | A. Novo | I. García-Cadenas | M. Cervera | M. Artola | A. Bermúdez | S. Monsalvo | Alfons Serrano-Maestro | B. Soria | R. Fernández-Martín | A. Martínez | Alberto Giménez Conca